Colgate-Palmolive
CL NYSE· Household Products
Last close · Oct 26, 2026
$93.10
KIRA · Stoqly’s AI analyst, in plain words
- Colgate-Palmolive had $20.4B of revenue in fiscal 2025, up 1.4% on the year before. Over five years, revenue changed +4.4% a year on average.
- Its operating margin was 16.2%, down 5.0 pts: of every 100 in sales, about 16 is left after running the business.
- Colgate-Palmolive made $2.1B of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −0.4% a year.
- Free cash flow was $3.6B in fiscal 2025, 17.8% of revenue.
- Colgate-Palmolive returned $3.0B to shareholders in fiscal 2025, 83% of free cash flow. The diluted share count fell 1.5%.
- Colgate-Palmolive owes $6.4B more than it holds in cash, about 1.6 years of operating profit.
Market cap
$74.6B
P/E
36.8x
Revenue
$20.4B
Net income
$2.1B
Free cash flow
$3.6B
Operating margin
16.2%
Colgate-Palmolive in 30 seconds · fiscal 2025
Are sales growing?
+1.4%
Only a little. Sales grew 1.4% last year.
Does it make a profit?
10.5%
Yes. It keeps 10.5% of every sale as profit.
Does profit turn into cash?
17.8%
Yes. 17.8% of sales ends up as free cash.
Is debt under control?
1.6x
Keep an eye on it. Repaying its debt would take 1.6 years of operating profit.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
36.8x
One share costs 36.8 times its yearly profit per share. Typical for its sector: 24.2x.
What Colgate-Palmolive does
Colgate-Palmolive makes and sells everyday household and personal care products and pet food. Its products are marketed in over 200 countries and territories. It sells toothpaste, toothbrushes and mouthwash under names such as Colgate, elmex and Tom's of Maine, and soaps, shower gels and deodorants such as Palmolive, Softsoap and Speed Stick. It also sells dishwashing liquids, household cleaners and fabric conditioners such as Ajax, Fabuloso and Suavitel. The company has two segments. Oral, Personal and Home Care brought in 44%, 17% and 16% of 2025 net sales. The Hill's Pet Nutrition segment, which sells Hill's Science Diet and Prescription Diet through pet stores, vets and online retailers, brought in 23%. Other customers include retailers, wholesalers and distributors. Walmart and its affiliates accounted for about 11% of net sales in 2025, and no other customer was as large. Colgate-Palmolive had about 33,600 employees in over 100 countries at the end of 2025.
Biggest risks, in its own words
- Its dependence on international sales, which exposes it to currency swings and political and economic instability.
- Strong competition and a fast-changing retail world, including online and direct-to-consumer sellers.
- Needing to develop and launch new products that shoppers want.
- Swings in the cost of raw and packaging materials such as resins, oils, pulp and tallow.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 23, 2026
- Legal name
- COLGATE-PALMOLIVE COMPANY
- CIK
- 0000021665
Colgate-Palmolive · CL
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B |
| Revenue growth | 5.8% | 3.1% | 8.3% | 3.3% | 1.4% |
| Gross margin | 59.6% | 57.0% | 58.2% | 60.5% | 60.1% |
| Operating margin | 19.1% | 16.1% | 20.5% | 21.2% | 16.2% |
| Net income | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B |
| Net margin | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% |
| Diluted EPS | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 |
| Cash | |||||
| Cash from operations | $3.3B | $2.6B | $3.7B | $4.1B | $4.2B |
| Capital expenditure | $567M | $696M | $705M | $561M | $564M |
| Free cash flow | $2.8B | $1.9B | $3.0B | $3.5B | $3.6B |
| FCF margin | 15.8% | 10.4% | 15.6% | 17.6% | 17.8% |
| Dividends paid | $1.7B | $1.7B | $1.7B | $1.8B | $1.8B |
| Share buybacks | $1.3B | $1.3B | $1.1B | $1.7B | $1.2B |
| Share count change | −1.3% | −1.1% | −1.1% | −0.7% | −1.5% |
| Debt and strength | |||||
| Cash and short-term investments | $832M | $775M | $1.1B | $1.3B | $1.4B |
| Debt incl. finance leases | $7.2B | $8.8B | $8.2B | $7.0B | $7.8B |
| Shareholders' equity | $609M | $401M | $609M | $212M | $54.0M |
| Net debt / EBITDA | 1.6x | 2.3x | 1.6x | 1.2x | 1.6x |
| Current ratio | 1.1x | 1.3x | 1.1x | 0.9x | 0.8x |
| Interest coverage | 27.8x | 17.3x | 13.9x | 14.6x | 12.4x |
| Returns and quality | |||||
| Return on capital | 33.9% | 26.5% | 34.3% | 45.9% | 37.3% |
| Piotroski F-score | 6 | 6 | 8 | 7 | 5 |
| Altman Z'' | 7.0 | 6.9 | 6.9 | 7.0 | 6.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$57.1M
8 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Colgate-Palmolive · CL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Colgate-Palmolive CL | $74.6B | 1.4% | 16.2% | 17.8% | 37.3% | 36.8x | 5 |
| Kimberly-Clark KMB | $36.5B | −2.1% | 14.3% | 10.0% | 21.5% | 18.6x | 6 |
| Church & Dwight CHD | $25.1B | 1.6% | 17.4% | 17.6% | 14.6% | 33.8x | 6 |
| Reynolds Consumer Products REYN | $4.9B | 0.7% | — | 8.5% | 9.9% | 14.7x | 5 |
| Central Garden & Pet CENT | $2.8B | −2.2% | 8.0% | 9.3% | 9.7% | 16.8x | 8 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $93.10 a share, the company is worth $74.6B: 36.8 times its earnings of the last four quarters.
Colgate-Palmolive grew sales faster than 3 of its 4 similar companies. Its P/E is higher than 4 of 4.
Source: SEC EDGAR XBRL filings (CIK 0000021665). Data updated October 9, 2026. For information only — not investment advice. Check the original filings before relying on any figure.